Events

OncoArendi will be present at the following events

BioEurope Berlin - November 6-8

OncoArendi will present the company during BioEurope in Berlin on the 7th of November at 3PM in room M3, level 3 during the Oncology track. 

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 - 30, 2017

Philadelphia, Pennsylvania, USA

OncoArendi will present a poster on the Development of OATD-02, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. (Poster Session B, Sunday Oct 29, 2017 12:30 PM - 4:00 PM, Hall E poster)

ERS - 9-13 September 2017 Milan

OncoArendi will present a poster on The Therapeutic Efficacy of OAT-889 (DualAMCase/CHIT1 Inhibitor) in Comparison to Montelukast in HDM-induced Model of Chronic Airway Inflammation in Mice, on Wednesday 13th, 10th at 8:30 AM. (link to the poster)

ESMO - 8-12 September 2017 Madrid

OncoArendi will present a poster on the development of a novel arginase 1 and 2 inhibitor for cancer immunotherapy, on Sunday, 10th at 1PM. (link: OAT-1746 ESMO 2017)

ATS - Washington 19-24 May 2017

A poster will be presented on Monday, 22nd of May from 9AM (link: poster OAT-889 ATS 2017)

http://conference.thoracic.org